0001127602-22-007174.txt : 20220228
0001127602-22-007174.hdr.sgml : 20220228
20220228191606
ACCESSION NUMBER: 0001127602-22-007174
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220228
FILED AS OF DATE: 20220228
DATE AS OF CHANGE: 20220228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAIN ALAN J
CENTRAL INDEX KEY: 0001227372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30111
FILM NUMBER: 22692893
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEXICON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001062822
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 760474169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2445 TECHNOLOGY FOREST BLVD.
STREET 2: SUITE 1100
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
BUSINESS PHONE: 2818633000
MAIL ADDRESS:
STREET 1: 2445 TECHNOLOGY FOREST BLVD.
STREET 2: SUITE 1100
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON PHARMACEUTICALS, INC./DE
DATE OF NAME CHANGE: 20070426
FORMER COMPANY:
FORMER CONFORMED NAME: LEXICON GENETICS INC/TX
DATE OF NAME CHANGE: 20000126
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-28
0001062822
LEXICON PHARMACEUTICALS, INC.
LXRX
0001227372
MAIN ALAN J
2445 TECHNOLOGY FOREST BLVD.
11TH FLOOR
THE WOODLANDS
TX
77381
1
EVP, Innov & Chem Sciences
Common Stock
2022-02-28
4
M
0
22373
A
163068
D
Common Stock
2022-02-28
4
M
0
23300
A
186368
D
Common Stock
2022-02-28
4
M
0
8977
A
195345
D
Common Stock
2022-02-28
4
F
0
19756
2.85
D
175589
D
Restricted Stock Units
2022-02-28
4
M
0
22373
D
Common Stock
22373
0
D
Restricted Stock Units
2022-02-28
4
M
0
23300
D
Common Stock
23300
23300
D
Restricted Stock Units
2022-02-28
4
M
0
8977
D
Common Stock
8977
17953
D
Each restricted stock unit represents a contingent right to receive one share of common stock.
Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter.
Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
/s/ Alan J. Main, Ph.D.
2022-02-28